Beck-Nielsen, S. S., Brock-Jacobsen, B., Gram, J., Brixen, K. & Jensen, T. K. Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur. J. Endocrinol. 160, 491–497 (2009).
Endo, I. et al. Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr. J. 62, 811–816 (2015).
Rafaelsen, S., Johansson, S., Ræder, H. & Bjerknes, R. Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications. Eur. J. Endocrinol. 174, 125–136 (2016).
Foster, B. L. et al. Rare bone diseases and their dental, oral, and craniofacial manifestations. J. Dent. Res. 93, 7S–19S (2014).
Article PubMed PubMed Central Google Scholar
Foster, B. L., Nociti, F. H. & Somerman, M. J. The rachitic tooth. Endocr. Rev. 35, 1–34 (2014).
Hanisch, M., Bohner, L., Sabandal, M. M. I., Kleinheinz, J. & Jung, S. Oral symptoms and oral health-related quality of life of individuals with x-linked hypophosphatemia. Head. Face Med. 15, 8 (2019).
Article PubMed PubMed Central Google Scholar
Salmon, B. et al. Abnormal osteopontin and matrix extracellular phosphoglycoprotein localization, and odontoblast differentiation, in X-linked hypophosphatemic teeth. Connect. Tissue Res. 55, 79–82 (2014).
Baroncelli, G. I. et al. Prevalence and pathogenesis of dental and periodontal lesions in children with X-linked hypophosphatemic rickets. Eur. J. Paediatr. Dent. 7, 61–66 (2006).
Baroncelli, G. I. et al. Pulp chamber features, prevalence of abscesses, disease severity, and PHEX mutation in X-linked hypophosphatemic rickets. J. Bone Miner. Metab. 39, 212–223 (2021).
Lo, S. H., Lachmann, R., Williams, A., Piglowska, N. & Lloyd, A. J. Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study. Qual. Life Res. 29, 1883–1893 (2020).
Article PubMed PubMed Central Google Scholar
Salmon, B. et al. MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia. PLoS ONE 8, e56749 (2013).
Article PubMed PubMed Central Google Scholar
Coyac, B. R. et al. Tissue-specific mineralization defects in the periodontium of the Hyp mouse model of X-linked hypophosphatemia. Bone 103, 334–346 (2017).
Hoshino, M. et al. Claudin rather than occludin is essential for differentiation in rat incisor odontoblasts. Oral. Dis. 14, 606–612 (2008).
Järvinen, E., Shimomura-Kuroki, J., Balic, A., Jussila, M. & Thesleff, I. Mesenchymal Wnt/β-catenin signaling limits tooth number. Development 145, dev158048 (2018).
Zhao, Y., Yuan, X., Bellido, T. & Helms, J. A. A correlation between Wnt/Beta-catenin signaling and the rate of dentin secretion. J. Endod. 45, 1357–1364.e1 (2019).
Zhu, X. et al. Intra-epithelial requirement of canonical Wnt signaling for tooth morphogenesis *. J. Biol. Chem. 288, 12080–12089 (2013).
Article PubMed PubMed Central Google Scholar
Kim, T.-H. et al. Constitutive stabilization of ß-catenin in the dental mesenchyme leads to excessive dentin and cementum formation. Biochem. Biophys. Res. Commun. 412, 549–555 (2011).
Zhao, Y., Yuan, X., Liu, B., Tulu, U. S. & Helms, J. A. Wnt-responsive odontoblasts secrete new dentin after superficial tooth injury. J. Dent. Res. 97, 1047–1054 (2018).
Article PubMed PubMed Central Google Scholar
Palacios, J. et al. Differential spatiotemporal expression of E- and P-cadherin during mouse tooth development. Int. J. Dev. Biol. 39, 663–666 (1995).
Hermans, F., Hemeryck, L., Lambrichts, I., Bronckaers, A. & Vankelecom, H. Intertwined signaling pathways governing tooth development: a give-and-take between canonical Wnt and Shh. Front. Cell Dev. Biol. 9, 758203 (2021).
Article PubMed PubMed Central Google Scholar
Kornsuthisopon, C., Photichailert, S., Nowwarote, N., Tompkins, K. A. & Osathanon, T. Wnt signaling in dental pulp homeostasis and dentin regeneration. Arch. Oral. Biol. 134, 105322 (2022).
Martin, A. et al. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling. FASEB J. 25, 2551–2562 (2011).
Article PubMed PubMed Central Google Scholar
Lu, Y. et al. The biological function of DMP-1 in osteocyte maturation is mediated by Its 57-kDa C-terminal fragment. J. Bone Miner. Res. 26, 331–340 (2011).
Simsek Kiper, P. O. et al. Cortical-bone fragility—insights from sFRP4 deficiency in Pyle’s disease. N. Engl. J. Med. 374, 2553–2562 (2016).
Palomo, T., Glorieux, F. H. & Rauch, F. Circulating sclerostin in children and young adults with heritable bone disorders. J. Clin. Endocrinol. Metab. 99, E920–E925 (2014).
Guirado, E. et al. Disrupted protein expression and altered proteolytic events in hypophosphatemic dentin can be rescued by dentin matrix protein 1. Front. Physiol 11, 82 (2020).
Article PubMed PubMed Central Google Scholar
Baron, R. & Kneissel, M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19, 179–192 (2013).
Ruppe, M. D. X-Linked Hypophosphatemia. in GeneReviews(®) (eds Adam, M. P. et al.) (University of Washington, Seattle, 1993).
Kornsuthisopon, C. et al. Non-canonical Wnt signaling participates in Jagged1-induced osteo/odontogenic differentiation in human dental pulp stem cells. Sci. Rep. 12, 7583 (2022).
Article PubMed PubMed Central Google Scholar
Eapen, A. et al. Calcium-mediated stress kinase activation by DMP1 promotes osteoblast differentiation*. J. Biol. Chem. 285, 36339–36351 (2010).
Article PubMed PubMed Central Google Scholar
Eapen, A. et al. Dentin phosphophoryn activates smad protein signaling through Ca2+-calmodulin-dependent protein kinase II in undifferentiated mesenchymal cells. J. Biol. Chem. 288, 8585–8595 (2013).
Article PubMed PubMed Central Google Scholar
Narayanan, K. et al. Dual functional roles of dentin matrix protein 1 implications in biomineralization and gene transcription by activation of intracellular Ca2+ store. J. Biol. Chem. 278, 17500–17508 (2003).
Ann, E.-J. et al. Wnt5a controls Notch1 signaling through CaMKII-mediated degradation of the SMRT corepressor protein. J. Biol. Chem. 287, 36814–36829 (2012).
Article PubMed PubMed Central Google Scholar
Tang, W. et al. A genome-wide RNAi screen for Wnt/beta-catenin pathway components identifies unexpected roles for TCF transcription factors in cancer. Proc. Natl Acad. Sci. USA 105, 9697–9702 (2008).
Article PubMed PubMed Central Google Scholar
Schmidt, E. E. et al. GenomeRNAi: a database for cell-based and in vivo RNAi phenotypes, 2013 update. Nucleic Acids Res. 41, D1021–D1026 (2013).
Vijaykumar, A., Root, S. H. & Mina, M. Wnt/β-catenin signaling promotes the formation of preodontoblasts in vitro. J. Dent. Res. 100, 387–396 (2021).
Xu, M. et al. WNT10A mutation causes ectodermal dysplasia by impairing progenitor cell proliferation and KLF4-mediated differentiation. Nat. Commun. 8, 15397 (2017).
Article PubMed PubMed Central Google Scholar
Bae, C. H. et al. Wntless regulates dentin apposition and root elongation in the mandibular molar. J. Dent. Res. 94, 439–445 (2015).
Article PubMed PubMed Central Google Scholar
Kikuchi, A., Yamamoto, H., Sato, A. & Matsumoto, S. Wnt5a: its signalling, functions and implication in diseases. Acta Physiol. 204, 17–33 (2012).
Oishi, I. et al. The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells Devoted Mol. Cell. Mech. 8, 645–654 (2003).
Ni, X. et al. Low levels of serum sclerostin in adult patients with tumor-induced osteomalacia compared with X-linked hypophosphatemia. J. Clin. Endocrinol. Metab. 107, e361–e371 (2022).
Carpenter, K. A. et al. Sclerostin antibody improves phosphate metabolism hormones, bone formation rates, and bone mass in adult Hyp mice. Bone 154, 116201 (2022).
Carpenter, K. A. & Ross, R. D. Sclerostin antibody treatment increases bone mass and normalizes circulating phosphate levels in growing Hyp mice. J. Bone Miner. Res. 35, 596–607 (2019).
留言 (0)